Novel digitalis-like factor, marinobufotoxin, isolated from cultured Y-1 cells, and its hypertensive effect in rats

Hypertension

Volumn 49, Issue 1, 2007, Pages 209-214

  Yoshika, Masamichi ^a   Komiyama, Yutaka ^a   Konishi, Motomi ^b   Akizawa, Toshifumi ^b   Kobayashi, Takahisa ^c   Date, Mutsuhiro ^c   Kobatake, Shinzo ^c   Masuda, Midori ^a   Masaki, Hiroya ^a   Takahashi, Hakuo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b SETSUNAN UNIVERSITY   (Japan)

^c FUJIFILM Wako Pure Chemical Corporation   (Japan)

Author keywords

Adrenal gland; Digitalis like factor; ELISA; Hypertension; Marinobufotoxin; Mass spectrometry

Indexed keywords

ARGININE; DIGITALIS LIKE FACTOR; ESTER DERIVATIVE; ION; MARINOBUFOTOXIN; UNCLASSIFIED DRUG; BUFADIENOLIDE DERIVATIVE; CARDANOLIDE; CARDENOLIDE; DIGOXIN LIKE FACTORS; DIGOXIN-LIKE FACTORS; MARINOBUFAGENIN; MONOCLONAL ANTIBODY; SAPONIN;

ACCURACY; ADRENAL CORTEX CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL ACTIVITY; BLOOD PRESSURE; CELL CULTURE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; IMMUNOREACTIVITY; INFUSION; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION; SUPERNATANT; SYSTOLIC HYPERTENSION; TANDEM MASS SPECTROMETRY; URINARY EXCRETION; ADRENAL CORTEX; ANIMAL; ANTIBODY SPECIFICITY; CELL LINE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DRUG ADMINISTRATION; DRUG EFFECT; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; URINE; WISTAR RAT;

ADRENAL CORTEX; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BLOOD PRESSURE; BUFANOLIDES; CARDANOLIDES; CARDENOLIDES; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERTENSION; INJECTIONS, INTRAPERITONEAL; MALE; MASS SPECTROMETRY; RATS; RATS, WISTAR; SAPONINS;

EID: 33847682886     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000250433.64202.78     Document Type: Article

References (32)

1. de Wardener HE, Mills JH, Clanpham WF, Hayer CJ. Studies on the efferent mechanism of the sodium diuresis, which follows the administration of intravenous saline in the dog. Clin Sci(Lond). 1961;21:249-258.
2. Haddy FJ, Overbeck HW. The role of hormoral agents in volume expanded hypertension. Life Sci. 1976;19:935-948.
3. Blaustein MP. Sodium inons, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol. 1977;232:C165-C175.
4. Schoner W. Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem. 2002;269:2440-2448.
5. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, Ludens JH. Identification and characterization of an ouabain-like compound from human plasma. Proc Natl Acad Sci U S A. 1991;88:6259-6263.
6. Pitzalis MV, Hamlyn JM, Messaggio E, Iacoviello M, Forleo C, Romito R, de Tommasi E, Rizzon P, Bianchi G, Manunta P. Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy. Eur J Heart Fail. 2006;8:179-186.
7. Bauer N, Muller-Ehmsen J, Kramer U, Hambarchian N, Zobel C, Schwinger RH, Neu H, Kirch U, Grunbaum EG, Schoner W. Ouabain-Like compound changes rapidly on physical exercise in humans and dogs. Hypertension. 2005;45:1024-1028.
8. Komiyama Y, Nishimura N, Munakata M, Mori T, Okuda K, Nishino N, Hirose S, Kosaka C, Masuda M, Takahashi H. Identification of endogenous ouabain in culture supernatant of PC12 cells. J Hypertens. 2001;19:229-236.
9. Bagrov AY, Fedorova OV, Dmitrieva RI, Howald WN, Hunter AP, Kuniznetsova EA, Shpen VM. Characterization of a urinary bufadienolide Na, K-ATPase inhibitory patients after myocardial infarction. Hypertension. 1998;31:1097-1103.
10. + ATPase inhibition during voluntary hypoventilation. Hypertension. 1995;26:781-788.
11. Fedorova OV, Kolodkin NI, Agalakova NI, Namikas AR, Bzhelyansky A, St-Louis J, Lakatta EG, Bagrov AY. Antibody to MBG lowers blood pressure in pregnant rats on a high NaCl intake. J Hypertens. 2005;23:835-842.
12. Kennedy DJ, Vetteth S, Periyasamy SM, Kanji M, Fedorova L, Khouri S, Kahaleh MB, Xie Z, Malhotra D, Kolodkin NI, Lakatta EG, Fedorova OV, Bagrov AY, Shapiro JI. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension. 2006;47:488-495.
13. Krenn L, Kopp B. Bufadienolides from animal and plant sources. Phytochemistry. 1998;48:1-29.
14. Lichtstein D, Gati I, Samuclov S, Berson D, Rozenmann Y, Landau L, Deutsch J. Identification of digitalis-like compounds in human cataractous lenses. Eur J Biochem. 1993;216:261-268.
15. Li S-Q, Eim C, Kirch U, Lang RE, Schoner W. Bovine adrenals and hypothalamus are a major source of proscillaridin A-and ouabain- immunoreactivities. Life Sci. 1998;62:1023-1033.
16. Komiyama Y, Dong XH, Nishimura N, Masaki H, Yoshika M, Masuda M, Takahashi H. A novel endogenous digitalis, telecinobufagin, exhibits elevated plasma levels in patients with terminal renal failure. Clin Biochem. 2005;38:36-45.
17. Matsukawa M, Akizawa T, Ohigashi M, Morris JF, Butler VP, Yoshioka M. A novel bufadienolide, marinosin, in the skin of the giant toad, Bufo marinus. Chem Pharm Bull. 1997;45:249-254.
18. Hosoda H, Sakai Y, Yoshida H, Nambara T. Enzyme labeling of steroids by the activated ester method. Chem Pharm Bull. 1979;29:2147-2150.
19. Köhler G, Milstein C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol. 1976;6:511-519.
20. Komiyama Y, Mori T, Murakami T, Masuda M, Takahashi H. Production of ouabain-like factors of hypothaloma-pituitary origin, determined by a sensitive ELISA for ouabain, is increased in DOCA-salt hypertensive rats. Pathophysiology. 1995;2:35-40.
21. Doris PA, Hayward-Lester A, Bourne D, Stocco DM. Ouabain production by cultured adrenal cells. Endocrinology. 1996;137:533-539.
22. Hamlyn JM, Laredo J, Shah JR, Lu ZR, Hamilton BP. 11-Hydroxylation in the biosynthesis of endogenous ouabain: multiple implications. Ann N Y Acad Sci. 2003;986:685-693.
23. Renata I, Bagrov AY, Lalli E, Sassone-Corsi P, Stocco DM, Doris PA. Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that is independent of cholesterol side-chain cleavage. Hypertension. 2000;36:442-448.
24. Butler VP, Morris JF, Akizawa T, Matsukawa M, Keating P, Hardart A, Furman I. Heterogeneity and lability of endogenous digitalis-like substances in plasma of the toad, Bufo marinus. Am J Physiol. 1996;271:325-332.
25. Manunta P, Hamilton BP, Hamlyn JM. Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. Am J Physiol Regul Integr Comp Physiol. 2006;290:R553-R559.
26. Sich B, Kirch U, Tepel M, Zidek W, Schoner W. Pulse pressure correlates in humans with a proscillaridin A immunoreactive compound. Hypertension. 1996;27:1073-1078.
27. Fedorova OV, Lakatta EG, Bagrov AY. Endogenous Na, K pump ligands are differentially regulated during acute NaCl loading Dahl rats. Circulation. 2000;102:3009-3014.
28. Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, Bagrov AY. Endogenous ligand of alpha (1) sodium pump, marinobufagenin, is a novel mediator of a sodium chloride-dependent hypertension. Circulation. 2002;105:1122-1127.
29. Fridman AI, Matveev SA, Agalakova NI, Fedorova OV, Lakatta EG, Bagrov AY. Marinobufagenin, an endogenous ligand of apha-1 sodium pump, is a marker of congestive heart failure severity. J Hypertens. 2002;20:1189-1194.
30. Vu HV, Ianosi-Irimie MR, Pridjian CA, Whitbred JM, Durst JM, Bagrov AY, Fedorova OV, Pridjian G, Puschett JB. Involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol. 2005;25:520-528.
31. i - independent signaling in C7-MDCK cells. J Biol Chem. 2005;280:832-839.
32. Cheung WJ, Kent MA, El-Shahat E, Wang H, Tan J, White R, Leenen FH. Central and peripheral renin-angiotensin systems in ouabain-induced hypertension. Am J Physiol Heart Circ Physiol. 2006;291:H624-H630.